EMA
approval
· 2025-04-25
First treatment against severe thyroid eye disease
Summary
The European Medicines Agency approved Tepezza (teprotumumab) as the first treatment for severe thyroid eye disease, offering significant symptom improvements i…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Tepezza significantly improves symptoms for patients with moderate-to-severe TED